Complications Following Radioembolization with Yttrium-90 Microspheres: A Comprehensive Literature Review

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 9, 2009, Pages 1121-1130

  Riaz, Ahsun ^a   Lewandowski, Robert J ^a   Kulik, Laura M ^a   Mulcahy, Mary F ^a   Sato, Kent T ^a   Ryu, Robert K ^a   Omary, Reed A ^a   Salem, Riad ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; MACROSALB TC 99M; MICROSPHERE; YTTRIUM 90;

ABDOMINAL INJURY; AORTOGRAPHY; ARTIFICIAL EMBOLISM; BILE DUCT NECROSIS; BILE DUCT OBSTRUCTION; BILIRUBIN BLOOD LEVEL; BILOMA; BLOOD VESSEL INJURY; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; CHOLECYSTECTOMY; CHOLECYSTITIS; COIL EMBOLIZATION; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; EVIDENCE BASED MEDICINE; GASTRODUODENAL ARTERY; GASTROINTESTINAL TRACT; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER TUMOR; LYMPHOCYTOPENIA; NEUROENDOCRINE TUMOR; PARTICLE SIZE; PNEUMONIA; PORTAL HYPERTENSION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INDUCED LIVER DISEASSE; RADIOFREQUENCY ABLATION; REVIEW; STOMACH ULCER; TUMOR GROWTH;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RADIATION INJURIES;

EID: 69249213965     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.05.030     Document Type: Review

References (59)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Bosch F.X., Ribes J., Diaz M., and Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 suppl (2004) S5-S16
3. Michel J., Suc B., Montpeyroux F., et al. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol 26 (1997) 1274-1280
4. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
5. Kulik L.M., Atassi B., van Holsbeeck L., et al. Yttrium-90 microspheres (TheraSphere(R)) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94 (2006) 572-586
6. Lu D.S., Yu N.C., Raman S.S., et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 234 (2005) 954-960
7. Maddala Y.K., Stadheim L., Andrews J.C., et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 10 (2004) 449-455
8. Lencioni R., and Crocetti L. Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol 10 (2007) 38-46
9. Takayasu K., Arii S., Ikai I., et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131 (2006) 461-469
10. Carr B.I. Hepatic arterial 90yttrium glass microspheres (TheraSphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients. Liver Transpl 10 suppl (2004) S107-S110
11. Salem R., Lewandowski R.J., Atassi B., et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16 (2005) 1627-1639
12. Kulik L.M., Carr B.I., Mulcahy M.F., et al. Safety and efficacy of (90)Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47 (2007) 71-81
13. Lewandowski R.J., Thurston K.G., Goin J.E., et al. 90y microsphere (therasphere) treatment for unresectable colorectal cancer metastases of the liver: Response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol 16 (2005) 1641-1651
14. Gray B., Van Hazel G., Hope M., et al. Randomised trial of sir-spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12 (2001) 1711-1720
15. Rhee T.K., Lewandowski R.J., Liu D.M., et al. 90Y radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 247 (2008) 1029-1035
16. Kennedy A.S., Dezarn W.A., McNeillie P., et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 31 (2008) 271-279
17. Minagawa M., Makuuchi M., Torzilli G., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231 (2000) 487-499
18. Bruix J., Sherman M., Llovet J.M., et al., Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol 35 (2001) 421-430
19. Yoon C.J., Chung J.W., Cho B.H., et al. Hepatocellular carcinoma in the caudate lobe of the liver: Angiographic analysis of tumor-feeding arteries according to subsegmental location. J Vasc Interv Radiol 19 (2008) 1543-1550
20. Liu D.M., Salem R., Bui J.T., et al. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16 (2005) 911-935
21. Murthy R., Nunez R., Szklaruk J., et al. Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications. Radiographics 25 suppl 1 (2005) S41-S55
22. Cosin O., Bilbao J.I., Alvarez S., de Luis E., Alonso A., and Martinez-Cuesta A. Right gastric artery embolization prior to treatment with yttrium-90 microspheres. Cardiovasc Intervent Radiol 30 (2007) 98-103
23. Salem R., Lewandowski R.J., Sato K.T., et al. Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol 10 (2007) 12-29
24. Lewandowski R.J., Sato K.T., Atassi B., et al. Radioembolization with 90Y microspheres: Angiographic and technical considerations. Cardiovasc Intervent Radiol 30 (2007) 571-592
25. Hamami M.E., Poeppel T.D., Muller S., et al. SPECT/CT with 99mTC-MAA in radioembolization with 90y microspheres in patients with hepatocellular cancer. J Nucl Med 50 (2009) 688-692
26. TheraSphere yttrium-90 microspheres [package insert] (2004), MDS Nordion, Kanata, ON, Canada
27. Sato K., Lewandowski R.J., Bui J.T., et al. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 29 (2006) 522-529
28. Salem R., Thurston K.G., Carr B.I., Goin J.E., and Geschwind J.F. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 13 suppl (2002) S223-S229
29. Salem R., and Thurston K.G. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17 (2006) 1251-1278
30. SIR-Spheres yttrium-90 microspheres [package insert] (2004), Sirtex Medical, Lane Cove, Australia
31. Van Hazel G., Blackwell A., Anderson J., et al. Randomised phase 2 trial of sir-spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88 (2004) 78-85
32. Kennedy A.S., Coldwell D., Nutting C., et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65 (2006) 412-425
33. Murthy R., Xiong H., Nunez R., et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16 (2005) 937-945
34. Young J.Y., Rhee T.K., Atassi B., et al. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol 18 (2007) 1375-1382
35. Sangro B., Gil-Alzugaray B., Rodriguez J., et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 112 (2008) 1538-1546
36. Kennedy A.S., McNeillie P., Dezarn W.A., et al. Treatment parameters and outcome in 680 treatments of internal radiation with resin (90)Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys (2009). http://www.ncbi.nlm.nih.gov/pubmed/19157721 (in press). Available at http://www.ncbi.nlm.nih.gov/pubmed/19157721 Accessed January 19, 2009
37. Atassi B., Bangash A.K., Lewandowski R.J., et al. Biliary sequelae following radioembolization with yttrium-90 microspheres. J Vasc Interv Radiol 19 (2008) 691-697
38. Rhee T.K., Naik N.K., Deng J., et al. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional mr imaging with anatomic MR imaging. J Vasc Interv Radiol 19 (2008) 1180-1186
39. Ibrahim S.M., Nikolaidis P., Miller F.H., et al. Radiologic findings following y90 radioembolization for primary liver malignancies. Abdom Imaging (2008). http://www.ncbi.nlm.gov/pubmed/18777189 (in press). Available at http://www.ncbi.nlm.gov/pubmed/18777189 Accessed September 7, 2008
40. Ng S.S., Yu S.C., Lai P.B., and Lau W.Y. Biliary complications associated with selective internal radiation (SIR) therapy for unresectable liver malignancies. Dig Dis Sci 53 (2008) 2813-2817
41. Gaba R., Ibrahim S., Ryu R.K., et al. Safety of Y90 radioembolization in lobar and segmental biliary obstruction. Presented at the 34th Annual Scientific Meeting of the Society of Interventional Radiology (March 9, 2009) San Diego, CA
42. Yu J.S., Kim K.W., Jeong M.G., Lee D.H., Park M.S., and Yoon S.W. Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol 25 (2002) 270-274
43. Salem R., and Thurston K.G. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 17 (2006) 1425-1439
44. Ayav A., Habib N., and Jiao L.R. Portal hypertension secondary to 90yttrium microspheres: An unknown complication. J Clin Oncol 23 (2005) 8275-8276
45. Jakobs T.F., Saleem S., Atassi B., et al. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with (90)Yttrium microspheres. Dig Dis Sci 53 (2008) 2556-2563
46. Gaba R.C., Lewandowski R.J., Kulik L.M., et al. Radiation lobectomy: Preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 16 (2009) 1587-1596
47. Leung T.W., Lau W.Y., Ho S.K., et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33 (1995) 919-924
48. Salem R., Parikh P., Atassi B., et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol 31 (2008) 431-438
49. Roach III M., Gandara D.R., Yuo H.S., et al. Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors. J Clin Oncol 13 (1995) 2606-2612
50. Carretero C., Munoz-Navas M., Betes M., et al. Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol 102 (2007) 1216-1220
51. Murthy R., Brown D.B., Salem R., et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 18 (2007) 553-561
52. Mallach S., Ramp U., Erhardt A., Schmitt M., and Haussinger D. An uncommon cause of gastro-duodenal ulceration. World J Gastroenterol 14 (2008) 2593-2595
53. Szyszko T., Al-Nahhas A., Tait P., et al. Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres. Nucl Med Commun 28 (2007) 21-24
54. Neff R., Abdel-Misih R., Khatri J., et al. The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors. Cancer Invest 26 (2008) 173-177
55. South C.D., Meyer M.M., Meis G., et al. Yttrium-90 microsphere induced gastrointestinal tract ulceration. World J Surg Oncol 6 (2008) 93
56. Murthy R., Eng C., Krishnan S., et al. Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol 18 (2007) 1588-1591
57. Wiggins E., Ibrahim S.M., Lewandowski R.J., Sato K.T., Omary R.A., Salem R., et al. Effect of chemotherapy on hepatic vasculature in patients undergoing Y-90 radioembolization for metastatic disease. Presented at the 33rd Annual Scientific Meeting of the Society of Interventional Radiology (March 19, 2008) Washington, DC
58. Leong Q.M., Lai H.K., Lo R.G., Teo T.K., Goh A., and Chow P.K. Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery. J Vasc Interv Radiol 20 (2009) 833-836
59. Lilly M.P., Reichman W., Sarazen Jr. A.A., and Carney Jr. W.I. Anatomic and clinical factors associated with complications of transfemoral arteriography. Ann Vasc Surg 4 (1990) 264-269